Search

everythinglearnresearchcommunity

for

Search:↓

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Low-dose flutamide effectively maintains reduced hirsutism with no side effects.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Flutamide reduces hair growth better but has more side effects.

Pentoxifylline helps hair regrowth in rats with hair loss.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

A woman's sudden hair loss was linked to azathioprine use despite normal enzyme levels, and improved after stopping the drug and starting treatment.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Cyproterone acetate is effective for treating hirsutism, but some patients may feel worse on low-dose maintenance therapy.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

New compounds with carborane showed anti-androgen effects similar to flutamide.

A woman developed lupus after taking hydroxyurea for two years.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Flutamide, delivered by solid lipid nanoparticles, could potentially treat hair loss.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.